4/13/2021
`
`SDNY CM/ECF NextGen Version 1.6
`
`Query
`
`Reports
`
`Utilities
`
`Help
`
`Log Out
`
`U.S. District Court
`
`Southern District of New York (Foley Square)
`
`CIVIL DOCKET FOR CASE #: 1:20-cv-05502-AJN
`
`ECF
`
`Regeneron Pharmaceuticals Inc. v. Novartis Pharma AG et al
`Assigned to: Judge Alison J. Nathan
`
`Cause: 15:1 Antitrust Litigation (Monopolizing Trade)
`
`
`
`Date Filed: 07/17/2020
`
`Jury Demand: Plaintiff
`
`Nature of Suit: 410 Anti-Trust
`Jurisdiction: Federal Question
`
`
`
`Plaintiff
`Regeneron Pharmaceuticals Inc.
`
`represented by Anish R Desai
`Weil, Gotshal & Manges
`767 5th Avenue
`New York, NY 10153
`212-310-8730
`Fax: 212-310-8007
`Email: anish.desai@weil.com
`
`LEAD ATTORNEY
`
`ATTORNEY TO BE NOTICED
`
`
`Brian Edward Ferguson
`Weil, Gotshal & Manges
`2001 M Street, NW
`Suite 600
`Washington, DC 20036
`202-682-7516
`Email: brian.ferguson@weil.com
`LEAD ATTORNEY
`
`ATTORNEY TO BE NOTICED
`
`
`
`
`Eric Shaun Hochstadt
`Weil, Gotshal & Manges LLP (NYC)
`767 Fifth Avenue
`New York, NY 10153
`(212)-310-8538
`Fax: (212) 310-8007
`Email: eric.hochstadt@weil.com
`
`LEAD ATTORNEY
`
`ATTORNEY TO BE NOTICED
`
`
`Jessica Falk
`Weil, Gotshal & Manges LLP (NYC)
`767 Fifth Avenue
`New York, NY 10153
`(212) 310-8000
`Fax: (212) 310-8007
`Email: jessica.falk@weil.com
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`1/17
`
`Regeneron Exhibit 1077.001
`
`

`

`4/13/2021
`
`SDNY CM/ECF NextGen Version 1.6
`LEAD ATTORNEY
`ATTORNEY TO BE NOTICED
`
`Michael Moiseyev
`Weil, Gotshal & Manges
`2001 M Street NW
`Suite 600
`Washington, DC 20036
`202-682-7235
`Email: michael.moiseyev@weil.com
`LEAD ATTORNEY
`ATTORNEY TO BE NOTICED
`
`Steven A. Newborn
`Weil, Gotshal & Manges LLP
`1300 Eye Street Nw, Ste. 900
`Washington, DC 20005
`(202) 682-7000
`Fax: (202) 857-0940
`Email: steven.newborn@weil.com
`LEAD ATTORNEY
`ATTORNEY TO BE NOTICED
`
`James Tori Evans
`Axinn, Veltrop & Harkrider, LLP
`114 West 47th Street
`New York, NY 10036
`212-728-2231
`Fax: 212-728-2201
`Email: james.evans@regeneron.com
`ATTORNEY TO BE NOTICED
`
`Lynda Quang Nguyen
`Jones Day (NYC)
`250 Vesey Street
`New York, NY 10281
`(212) 326-3939 x3884
`Fax: (212) 755-7306
`Email: lynda.nguyen@regeneron.com
`ATTORNEY TO BE NOTICED
`
`Petra Scamborova
`Regeneron Pharmaceuticals, Inc.
`777 Old Saw Mill River Road
`Tarrytown, NY 10591
`914-847-7611
`Email: petra.scamborova@regeneron.com
`ATTORNEY TO BE NOTICED
`
`Elizabeth S. Weiswasser
`Weil, Gotshal & Manges LLP (NYC)
`767 Fifth Avenue
`New York, NY 10153
`(212)-310-8022
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`2/17
`
`Regeneron Exhibit 1077.002
`
`

`

`4/13/2021
`
`V.
` Defendant
`Novartis Pharma AG
`
`Defendant
`Novartis Technology LLC
`
`SDNY CM/ECF NextGen Version 1.6
`Fax: (212)-310-8007
`Email: elizabeth.weiswasser@weil.com
`ATTORNEY TO BE NOTICED
`
`represented by Ian Thomas Simmons
`O'Melveny & Meyers LLP
`1625 Eye Street NW
`Washington, DC 20006
`(202)-383-5106
`Fax: (202)-383-5414
`Email: isimmons@omm.com
`
`LEAD ATTORNEY
`
`ATTORNEY TO BE NOTICED
`
`
`Benjamin Bradshaw
`O'Melveny & Meyers LLP
`1625 Eye Street NW
`Washington, DC 20006
`(202)-383-5163
`Fax: (202)-383-5414
`Email: bbradshaw@omm.com
`
`ATTORNEY TO BE NOTICED
`
`
`Stephen McIntyre
`O'Melveny & Myers, LLP (LA2)
`400 South Hope Street
`Los Angeles, CA 90071
`(213)-430-8382
`Fax: (213)-430-6407
`Email: smcintyre@omm.com
`
`ATTORNEY TO BE NOTICED
`
`represented by Ian Thomas Simmons
`(See above for address)
`
`LEAD ATTORNEY
`
`ATTORNEY TO BE NOTICED
`
`
`Benjamin Bradshaw
`(See above for address)
`
`ATTORNEY TO BE NOTICED
`
`
`Stephen McIntyre
`(See above for address)
`
`ATTORNEY TO BE NOTICED
`
`Defendant
`Novartis Pharmaceuticals Corporation
`
`represented by Ian Thomas Simmons
`(See above for address)
`
`LEAD ATTORNEY
`
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`3/17
`
`Regeneron Exhibit 1077.003
`
`

`

`4/13/2021
`
`SDNY CM/ECF NextGen Version 1.6
`ATTORNEY TO BE NOTICED
`
`Benjamin Bradshaw
`(See above for address)
`ATTORNEY TO BE NOTICED
`
`Stephen McIntyre
`(See above for address)
`ATTORNEY TO BE NOTICED
`
`Defendant
`Vetter Pharma International GMBH
`
`represented by Benjamin T Horton
`Marshall, Gerstein & Borun LLP
`233 S. Wacker Dr., 6300 Willis Tower
`Chicago, IL 60606
`(312)-474-9547
`Fax: (312)-474-0448
`Email: bhorton@marshallip.com
`ATTORNEY TO BE NOTICED
`
`
`
`
`Julianne Marie Hartzell
`Marshall, Gerstein & Borun LLP
`233 S. Wacker Dr., Suite 6300
`Chicago, IL 60606
`312-474-6625
`Email: jhartzell@marshallip.com
`ATTORNEY TO BE NOTICED
`
`
`
`Date Filed
`07/17/2020
`
`07/17/2020
`
`07/17/2020
`
`07/17/2020
`
`07/17/2020
`
`07/17/2020
`
`07/17/2020
`
`# Docket Text
`1 COMPLAINT against Novartis Pharma AG, Novartis Pharmaceuticals Corporation,
`Novartis Technology LLC, Vetter Pharma International GMBH. (Filing Fee $ 400.00,
`Receipt Number ANYSDC-20733541)Document filed by Regeneron Pharmaceuticals
`Inc...(Weiswasser, Elizabeth) (Entered: 07/17/2020)
`2 CIVIL COVER SHEET filed. (Attachments: # 1 Civil Cover Sheet Related Case
`Statement).(Weiswasser, Elizabeth) (Entered: 07/17/2020)
`3 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document
`filed by Regeneron Pharmaceuticals Inc...(Weiswasser, Elizabeth) (Entered: 07/17/2020)
`4 REQUEST FOR ISSUANCE OF SUMMONS as to Novartis Pharma AG, re: 1
`Complaint,. Document filed by Regeneron Pharmaceuticals Inc...(Weiswasser, Elizabeth)
`(Entered: 07/17/2020)
`5 REQUEST FOR ISSUANCE OF SUMMONS as to Novartis Pharmaceuticals
`Corporation, re: 1 Complaint,. Document filed by Regeneron Pharmaceuticals Inc...
`(Weiswasser, Elizabeth) (Entered: 07/17/2020)
`6 REQUEST FOR ISSUANCE OF SUMMONS as to Novartis Technology LLC, re: 1
`Complaint,. Document filed by Regeneron Pharmaceuticals Inc...(Weiswasser, Elizabeth)
`(Entered: 07/17/2020)
`7 REQUEST FOR ISSUANCE OF SUMMONS as to Vetter Pharma International GMBH,
`re: 1 Complaint,. Document filed by Regeneron Pharmaceuticals Inc...(Weiswasser,
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`4/17
`
`Regeneron Exhibit 1077.004
`
`

`

`4/13/2021
`
`07/17/2020
`
`07/17/2020
`
`07/20/2020
`
`07/20/2020
`
`07/20/2020
`07/20/2020
`
`07/20/2020
`
`07/20/2020
`
`07/20/2020
`
`07/22/2020
`
`07/27/2020
`
`07/27/2020
`
`07/27/2020
`
`SDNY CM/ECF NextGen Version 1.6
`Elizabeth) (Entered: 07/17/2020)
`8 NOTICE OF APPEARANCE by Elizabeth S. Weiswasser on behalf of Regeneron
`Pharmaceuticals Inc...(Weiswasser, Elizabeth) (Entered: 07/17/2020)
`9 NOTICE OF APPEARANCE by Eric Shaun Hochstadt on behalf of Regeneron
`Pharmaceuticals Inc...(Hochstadt, Eric) (Entered: 07/17/2020)
` CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is
`assigned to Judge Alison J. Nathan. Please download and review the Individual Practices
`of the assigned District Judge, located at https://nysd.uscourts.gov/judges/district-judges.
`Attorneys are responsible for providing courtesy copies to judges where their Individual
`Practices require such. Please download and review the ECF Rules and Instructions,
`located at https://nysd.uscourts.gov/rules/ecf-related-instructions..(dnh) (Entered:
`07/20/2020)
` Magistrate Judge Robert W. Lehrburger is so designated. Pursuant to 28 U.S.C. Section
`636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed
`before a United States Magistrate Judge. Parties who wish to consent may access the
`necessary form at the following link: https://nysd.uscourts.gov/sites/default/files/2018-
`06/AO-3.pdf. (dnh) (Entered: 07/20/2020)
` Case Designated ECF. (dnh) (Entered: 07/20/2020)
`10 ELECTRONIC SUMMONS ISSUED as to Novartis Pharma AG..(dnh) (Entered:
`07/20/2020)
`11 ELECTRONIC SUMMONS ISSUED as to Novartis Pharmaceuticals Corporation..(dnh)
`(Entered: 07/20/2020)
`12 ELECTRONIC SUMMONS ISSUED as to Novartis Technology LLC..(dnh) (Entered:
`07/20/2020)
`13 ELECTRONIC SUMMONS ISSUED as to Vetter Pharma International GMBH..(dnh)
`(Entered: 07/20/2020)
`14 SUMMONS RETURNED EXECUTED Summons and Complaint, served. Vetter Pharma
`International GMBH served on 7/20/2020, answer due 8/10/2020. Service was accepted
`by Tracie Blaskie. Document filed by Regeneron Pharmaceuticals Inc...(Weiswasser,
`Elizabeth) (Entered: 07/22/2020)
`15 MOTION for Anish R. Desai to Appear Pro Hac Vice . Filing fee $ 200.00, receipt
`number ANYSDC-20861387. Motion and supporting papers to be reviewed by
`Clerk's Office staff. Document filed by Regeneron Pharmaceuticals Inc.. (Attachments:
`# 1 Declaration of Anish R. Desai, # 2 New York State Certificate of Good Standing, # 3
`District of Columbia Certificate of Good Standing, # 4 Text of Proposed Order).(Desai,
`Anish) (Entered: 07/27/2020)
` >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No.
`15 MOTION for Anish R. Desai to Appear Pro Hac Vice . Filing fee $ 200.00, receipt
`number ANYSDC-20861387. Motion and supporting papers to be reviewed by
`Clerk's Office staff.. The document has been reviewed and there are no deficiencies.
`(vba) (Entered: 07/27/2020)
`16 MOTION for Michael R. Moiseyev to Appear Pro Hac Vice . Filing fee $ 200.00, receipt
`number ANYSDC-20861978. Motion and supporting papers to be reviewed by
`Clerk's Office staff. Document filed by Regeneron Pharmaceuticals Inc.. (Attachments:
`# 1 Affidavit of Michael R. Moiseyev, # 2 District of Columbia Certificate of Good
`Standing, # 3 Text of Proposed Order).(Moiseyev, Michael) (Entered: 07/27/2020)
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`5/17
`
`Regeneron Exhibit 1077.005
`
`

`

`4/13/2021
`07/27/2020
`
`07/27/2020
`
`07/27/2020
`
`07/27/2020
`
`07/27/2020
`
`07/29/2020
`
`07/30/2020
`
`07/30/2020
`
`07/31/2020
`
`07/31/2020
`
`07/31/2020
`
`08/03/2020
`
`08/04/2020
`
`08/04/2020
`
`SDNY CM/ECF NextGen Version 1.6
`17 MOTION for Steven Newborn to Appear Pro Hac Vice . Filing fee $ 200.00, receipt
`number ANYSDC-20862239. Motion and supporting papers to be reviewed by
`Clerk's Office staff. Document filed by Regeneron Pharmaceuticals Inc.. (Attachments:
`# 1 Affidavit of Steven Newborn, # 2 District of Columbia Certificate of Good Standing,
`# 3 New York State Certificate of Good Standing, # 4 Text of Proposed Order).(Newborn,
`Steven) (Entered: 07/27/2020)
`18 WAIVER OF SERVICE RETURNED EXECUTED. Novartis Pharma AG waiver sent on
`7/21/2020, answer due 9/21/2020. Document filed by Regeneron Pharmaceuticals Inc...
`(Weiswasser, Elizabeth) (Entered: 07/27/2020)
`19 WAIVER OF SERVICE RETURNED EXECUTED. Novartis Pharmaceuticals
`Corporation waiver sent on 7/21/2020, answer due 9/21/2020. Document filed by
`Regeneron Pharmaceuticals Inc...(Weiswasser, Elizabeth) (Entered: 07/27/2020)
`20 WAIVER OF SERVICE RETURNED EXECUTED. Novartis Technology LLC waiver
`sent on 7/21/2020, answer due 9/21/2020. Document filed by Regeneron Pharmaceuticals
`Inc...(Weiswasser, Elizabeth) (Entered: 07/27/2020)
` >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No.
`17 MOTION for Steven Newborn to Appear Pro Hac Vice . Filing fee $ 200.00,
`receipt number ANYSDC-20862239. Motion and supporting papers to be reviewed
`by Clerk's Office staff., 16 MOTION for Michael R. Moiseyev to Appear Pro Hac
`Vice . Filing fee $ 200.00, receipt number ANYSDC-20861978. Motion and
`supporting papers to be reviewed by Clerk's Office staff.. The document has been
`reviewed and there are no deficiencies. (vba) (Entered: 07/27/2020)
`21 NOTICE OF APPEARANCE by Petra Scamborova on behalf of Regeneron
`Pharmaceuticals Inc...(Scamborova, Petra) (Entered: 07/29/2020)
`22 NOTICE OF APPEARANCE by James Tori Evans on behalf of Regeneron
`Pharmaceuticals Inc...(Evans, James) (Entered: 07/30/2020)
`23 NOTICE OF INITIAL PRETRIAL CONFERENCE: Initial Conference set for
`10/30/2020 at 03:15 PM in Courtroom 906, U.S. Courthouse, 40 Centre Street, New
`York, NY 10007 before Judge Alison J. Nathan. Parties ordered to submit via ECF
`proposed case management plan and joint letter seven days before conference. (As
`further set forth in this Order.) (Signed by Judge Alison J. Nathan on 7/29/2020) (rjm)
`(Entered: 07/30/2020)
`24 ORDER granting 15 Motion for Anish R. Desai to Appear Pro Hac Vice (HEREBY
`ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered: 07/31/2020)
`25 ORDER granting 16 Motion for Michael R. Moiseyev to Appear Pro Hac Vice
`(HEREBY ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered:
`07/31/2020)
`26 ORDER granting 17 Motion for Steven Newborn to Appear Pro Hac Vice (HEREBY
`ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered: 07/31/2020)
`27 LETTER MOTION for Extension of Time to answer or otherwise respond to Plaintiff's
`Complaint addressed to Judge Alison J. Nathan from Eric S. Hochstadt dated August 3,
`2020. Document filed by Regeneron Pharmaceuticals Inc...(Hochstadt, Eric) (Entered:
`08/03/2020)
`28 ORDER granting 27 Letter Motion for Extension of Time. SO ORDERED. (Signed by
`Judge Alison J. Nathan on 8/4/2020) (ks) (Entered: 08/04/2020)
` Set/Reset Deadlines: Novartis Pharma AG answer due 10/19/2020; Novartis
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`6/17
`
`Regeneron Exhibit 1077.006
`
`

`

`4/13/2021
`
`08/11/2020
`
`08/24/2020
`
`08/24/2020
`
`08/24/2020
`
`08/25/2020
`
`09/03/2020
`
`09/03/2020
`
`09/03/2020
`
`SDNY CM/ECF NextGen Version 1.6
`Pharmaceuticals Corporation answer due 10/19/2020; Novartis Technology LLC answer
`due 10/19/2020; Vetter Pharma International GMBH answer due 10/19/2020. (ks)
`(Entered: 08/04/2020)
`29 NOTICE OF APPEARANCE by Brian Edward Ferguson on behalf of Regeneron
`Pharmaceuticals Inc...(Ferguson, Brian) (Entered: 08/11/2020)
`30 MOTION for Stephen J. McIntyre to Appear Pro Hac Vice . Filing fee $ 200.00, receipt
`number ANYSDC-21301391. Motion and supporting papers to be reviewed by
`Clerk's Office staff. Document filed by Novartis Pharma AG, Novartis Pharmaceuticals
`Corporation, Novartis Technology LLC. (Attachments: # 1 Declaration of Stephen J.
`McIntyre in Support of Motion for Admission Pro Hac Vice, # 2 California Certificate of
`Good Standing, # 3 Text of Proposed Order).(McIntyre, Stephen) (Entered: 08/24/2020)
`31 MOTION for Ian Simmons to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number
`ANYSDC-21302200. Motion and supporting papers to be reviewed by Clerk's Office
`staff. Document filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation,
`Novartis Technology LLC. (Attachments: # 1 Declaration of Ian Simmons in Support of
`Motion for Admission Pro Hac Vice, # 2 Pennsylvania Certificate of Good Standing, # 3
`District of Columbia Certificate of Good Standing, # 4 Text of Proposed Order).
`(Simmons, Ian) (Entered: 08/24/2020)
`32 MOTION for Benjamin G. Bradshaw to Appear Pro Hac Vice . Filing fee $ 200.00,
`receipt number ANYSDC-21303290. Motion and supporting papers to be reviewed by
`Clerk's Office staff. Document filed by Novartis Pharma AG, Novartis Pharmaceuticals
`Corporation, Novartis Technology LLC. (Attachments: # 1 Declaration of Benjamin G.
`Bradshaw in Support of Motion for Admission Pro Hac Vice, # 2 California Certificate of
`Good Standing, # 3 District of Columbia Certificate of Good Standing, # 4 Text of
`Proposed Order).(Bradshaw, Benjamin) (Entered: 08/24/2020)
` >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No.
`30 MOTION for Stephen J. McIntyre to Appear Pro Hac Vice . Filing fee $ 200.00,
`receipt number ANYSDC-21301391. Motion and supporting papers to be reviewed
`by Clerk's Office staff., 31 MOTION for Ian Simmons to Appear Pro Hac Vice .
`Filing fee $ 200.00, receipt number ANYSDC-21302200. Motion and supporting
`papers to be reviewed by Clerk's Office staff., 32 MOTION for Benjamin G.
`Bradshaw to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-
`21303290. Motion and supporting papers to be reviewed by Clerk's Office staff..
`The document has been reviewed and there are no deficiencies. (vba) (Entered:
`08/25/2020)
`33 MOTION for Benjamin T. Horton to Appear Pro Hac Vice . Filing fee $ 200.00, receipt
`number ANYSDC-21481872. Motion and supporting papers to be reviewed by
`Clerk's Office staff. Document filed by Vetter Pharma International GMBH.
`(Attachments: # 1 Affidavit in Support of Motion for Pro Hac Vice Admission of
`Benjamin T. Horton, # 2 Text of Proposed Order).(Horton, Benjamin) (Entered:
`09/03/2020)
` >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No.
`33 MOTION for Benjamin T. Horton to Appear Pro Hac Vice . Filing fee $ 200.00,
`receipt number ANYSDC-21481872. Motion and supporting papers to be reviewed
`by Clerk's Office staff. The document has been reviewed and there are no
`deficiencies. The applicant states in the affidavit due to COVID-19, cannot obtain
`Certificates of Good Standing within the required time frame. The applicant must
`submit Certificate from Illinois once received. (aea) (Entered: 09/03/2020)
`34 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Julianne M.
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`7/17
`
`Regeneron Exhibit 1077.007
`
`

`

`4/13/2021
`
`09/03/2020
`
`09/03/2020
`
`09/03/2020
`
`09/03/2020
`
`09/04/2020
`
`09/04/2020
`
`09/04/2020
`
`09/04/2020
`
`09/04/2020
`
`09/04/2020
`
`SDNY CM/ECF NextGen Version 1.6
`Hartzell to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-
`21483271. Motion and supporting papers to be reviewed by Clerk's Office staff.
`Document filed by Vetter Pharma International GMBH. (Attachments: # 1 Affidavit in
`Support of Motion for Admission Pro Hac Vice, # 2 Text of Proposed Order).(Hartzell,
`Julianne) Modified on 9/4/2020 (bcu). (Entered: 09/03/2020)
`35 ORDER granting 30 Motion for Stephen J. McIntyre to Appear Pro Hac Vice (HEREBY
`ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered: 09/03/2020)
`36 ORDER granting 31 Motion for Ian Simmons to Appear Pro Hac Vice (HEREBY
`ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered: 09/03/2020)
`37 ORDER granting 32 Motion for Benjamin G. Bradshaw to Appear Pro Hac Vice
`(HEREBY ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered:
`09/03/2020)
`38 ORDER granting 33 Motion for Benjamin T. Horton to Appear Pro Hac Vice (HEREBY
`ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered: 09/03/2020)
` >>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC
`VICE. Notice to RE-FILE Document No. 34 MOTION for Julianne M. Hartzell to
`Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-21483271.
`Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is
`deficient for the following reason(s): Attorney Affidavit not notarized.;. Re-file the
`motion as a Corrected Motion to Appear Pro Hac Vice - attach the correct signed
`PDF - select the correct named filer/filers - attach valid Certificates of Good
`Standing issued within the past 30 days - attach Proposed Order.. (bcu) (Entered:
`09/04/2020)
`39 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent
`Novartis AG for Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis
`Technology LLC. Document filed by Novartis Pharma AG, Novartis Pharmaceuticals
`Corporation, Novartis Technology LLC..(Simmons, Ian) (Entered: 09/04/2020)
`40 MOTION to Dismiss ., MOTION to Transfer Case or., MOTION to Stay (Motion to
`Dismiss, Transfer, or Stay). Document filed by Novartis Pharma AG, Novartis
`Pharmaceuticals Corporation, Novartis Technology LLC..(Simmons, Ian) (Entered:
`09/04/2020)
`41 MEMORANDUM OF LAW in Support re: 40 MOTION to Dismiss . MOTION to
`Transfer Case or. MOTION to Stay (Motion to Dismiss, Transfer, or Stay). . Document
`filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis
`Technology LLC..(Simmons, Ian) (Entered: 09/04/2020)
`42 DECLARATION of Ian Simmons in Support re: 40 MOTION to Dismiss . MOTION to
`Transfer Case or. MOTION to Stay (Motion to Dismiss, Transfer, or Stay).. Document
`filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis
`Technology LLC. (Attachments: # 1 Exhibit 1 - Copy of Novartis's complaint against
`Regeneron in Novartis Pharma AG v. Regeneron Pharm., Inc., No. 1:20-cv-00690-TJM-
`CFH (N.D.N.Y.), # 2 Exhibit 2 - Novartis's Complaint against Regeneron in the
`International Trade Commission, # 3 Exhibit 3 - Regeneron's Response to the Complaint
`and Notice of Investigation in the International Trade Commission, # 4 Exhibit 4 -
`Regeneron's Motion to Stay Novartis Pharma AG v. Regeneron Pharm., Inc., No. 1:20-
`cv-00690-TJM-CFH (N.D.N.Y.), # 5 Exhibit 5 - Copy of the article Regeneron Will
`Spend up to $620 Million in Capital Expenditure This Year, published in the Albany
`Business Review on Feb. 24, 2020).(Simmons, Ian) (Entered: 09/04/2020)
`43 MOTION to Dismiss ., MOTION to Transfer Case ., MOTION to Stay (Motion to
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`8/17
`
`Regeneron Exhibit 1077.008
`
`

`

`4/13/2021
`
`09/14/2020
`
`09/14/2020
`
`09/16/2020
`
`09/16/2020
`
`09/16/2020
`
`09/21/2020
`
`09/23/2020
`
`09/23/2020
`
`09/23/2020
`
`09/24/2020
`
`SDNY CM/ECF NextGen Version 1.6
`Dismiss, Transfer, or Stay). Document filed by Vetter Pharma International GMBH..
`(Horton, Benjamin) (Entered: 09/04/2020)
`44 AMENDED MOTION for Julianne M. Hartzell to Appear Pro Hac Vice . Motion and
`supporting papers to be reviewed by Clerk's Office staff. Document filed by Vetter
`Pharma International GMBH. (Attachments: # 1 Affidavit of Julianne M. Hartzell In
`Support of Corrected Motion for Admission Pro Hac Vice, # 2 Certificate of Good
`Standing, # 3 Text of Proposed Order).(Hartzell, Julianne) (Entered: 09/14/2020)
` >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No.
`44 AMENDED MOTION for Julianne M. Hartzell to Appear Pro Hac Vice . Motion
`and supporting papers to be reviewed by Clerk's Office staff. The document has
`been reviewed and there are no deficiencies. (aea) (Entered: 09/14/2020)
`45 MEMORANDUM OF LAW in Opposition re: 43 MOTION to Dismiss . MOTION to
`Transfer Case . MOTION to Stay (Motion to Dismiss, Transfer, or Stay)., 40 MOTION to
`Dismiss . MOTION to Transfer Case or. MOTION to Stay (Motion to Dismiss, Transfer,
`or Stay). . Document filed by Regeneron Pharmaceuticals Inc...(Hochstadt, Eric)
`(Entered: 09/16/2020)
`46 DECLARATION of Eric S. Hochstadt in Opposition re: 43 MOTION to Dismiss .
`MOTION to Transfer Case . MOTION to Stay (Motion to Dismiss, Transfer, or Stay)., 40
`MOTION to Dismiss . MOTION to Transfer Case or. MOTION to Stay (Motion to
`Dismiss, Transfer, or Stay).. Document filed by Regeneron Pharmaceuticals Inc..
`(Attachments: # 1 Exhibit 1- Email Chain Between Parties' Counsel, # 2 Exhibit 2 -
`Novartis's ITC Case Disclosure of Licensee Vetter, # 3 Exhibit 3 -ITC Case Schedule
`Proposals, # 4 Exhibit 4 - ITC Case Schedule, # 5 Exhibit 5 - French Competition
`Authority Enforcement Action Press Release, # 6 Exhibit 6 - Albany International Flight
`Routes, # 7 Exhibit 7 - Second Circuit Case Management Statistics).(Hochstadt, Eric)
`(Entered: 09/16/2020)
`47 DECLARATION of Kenneth S. Graham in Opposition re: 43 MOTION to Dismiss .
`MOTION to Transfer Case . MOTION to Stay (Motion to Dismiss, Transfer, or Stay)., 40
`MOTION to Dismiss . MOTION to Transfer Case or. MOTION to Stay (Motion to
`Dismiss, Transfer, or Stay).. Document filed by Regeneron Pharmaceuticals Inc...
`(Hochstadt, Eric) (Entered: 09/16/2020)
`48 ORDER granting 44 Motion for Julianne M. Hartzell to Appear Pro Hac Vice (HEREBY
`ORDERED by Judge Alison J. Nathan)(Text Only Order) (kwi) (Entered: 09/21/2020)
`49 REPLY MEMORANDUM OF LAW in Support re: 40 MOTION to Dismiss . MOTION
`to Transfer Case or. MOTION to Stay (Motion to Dismiss, Transfer, or Stay). . Document
`filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis
`Technology LLC..(Simmons, Ian) (Entered: 09/23/2020)
`50 LETTER MOTION for Extension of Time to File Answer re: 1 Complaint, addressed to
`Judge Alison J. Nathan from Ian Simmons dated September 23, 2020., LETTER
`MOTION to Adjourn Conference addressed to Judge Alison J. Nathan from Ian Simmons
`dated September 23, 2020. Document filed by Novartis Pharma AG, Novartis
`Pharmaceuticals Corporation, Novartis Technology LLC..(Simmons, Ian) (Entered:
`09/23/2020)
`51 REPLY MEMORANDUM OF LAW in Support re: 43 MOTION to Dismiss . MOTION
`to Transfer Case . MOTION to Stay (Motion to Dismiss, Transfer, or Stay). . Document
`filed by Vetter Pharma International GMBH..(Horton, Benjamin) (Entered: 09/23/2020)
`52 ORDER with respect to 50 Letter Motion for Extension of Time to Answer; with respect
`to 50 Letter Motion to Adjourn Conference. Plaintiff is hereby ORDERED to respond to
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`9/17
`
`Regeneron Exhibit 1077.009
`
`

`

`4/13/2021
`
`09/24/2020
`09/25/2020
`
`10/14/2020
`
`10/19/2020
`
`10/19/2020
`
`10/19/2020
`
`10/19/2020
`
`SDNY CM/ECF NextGen Version 1.6
`Defendants' requests by September 29, 2020. (Signed by Judge Alison J. Nathan on
`9/24/2020) (rro) (Entered: 09/24/2020)
` Set/Reset Deadlines: Responses due by 9/29/2020 (rro) (Entered: 09/24/2020)
`53 LETTER RESPONSE in Opposition to Motion addressed to Judge Alison J. Nathan from
`Eric S. Hochstadt dated September 25, 2020 re: 50 LETTER MOTION for Extension of
`Time to File Answer re: 1 Complaint, addressed to Judge Alison J. Nathan from Ian
`Simmons dated September 23, 2020. LETTER MOTION to Adjourn Conference
`addressed to Judge Alison J. Nathan from Ian Simmons dated September 23, 2020. .
`Document filed by Regeneron Pharmaceuticals Inc...(Hochstadt, Eric) (Entered:
`09/25/2020)
`54 ORDER. The Court is in receipt of Defendants' letter motion requesting that the Court
`extend Defendants' responsive pleading deadline from October 19, 2020 until 30 days
`after the Court resolves the Defendants' Motions to Dismiss, Transfer, or Stay, Dkt. Nos.
`40, 43, and that the Court continue the initial case management conference at least until
`after the parties' dispute over venue is resolved. Dkt. No. 50. The Court is also in receipt
`of the Plaintiff's opposition. Dkt. No. 53. Having carefully considered the parties'
`arguments, Defendants' request to extend their responsive pleading deadline until 30 days
`after the Court resolves their pending Motion to Dismiss, Transfer, or Stay, Dkt. No. 40,
`is hereby DENIED. In addition, Defendants' request to adjourn the initial case
`management conference is DENIED. In light of the COVID-19 public health crisis, the
`Court will not hold the initial conference in this case in person. Counsel should submit
`their proposed case management plan and joint letter seven days prior to the scheduled
`conference, as directed in the Court's Notice of Initial Pretrial Conference. In their joint
`letter, the parties should also indicate whether they can do without a conference
`altogether. If so, the Court may enter a case management plan and scheduling order and
`the parties need not appear. If not, the Court will hold the initial pretrial conference by
`telephone, albeit perhaps at a different time than the currently scheduled time. To that
`end, counsel should indicate in their joint letter all times on the date of the scheduled
`conference that they would be available for a telephone conference. In either case,
`counsel should review and comply with the Court's Emergency Individual Rules and
`Practices in Light of COVID-19, available at https://www.nysd.uscourts.gov/hon-alison-
`j-nathan. SO ORDERED. Denying 50 LETTER MOTION for Extension of Time to File
`Answer re: 1 Complaint, addressed to Judge Alison J. Nathan from Ian Simmons dated
`September 23, 2020. LETTER MOTION to Adjourn Conference addressed to Judge
`Alison J. Nathan from Ian Simmons dated September 23, 2020. Document filed by
`Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC.
`(Signed by Judge Alison J. Nathan on 10/14/2020) (rjm) (Entered: 10/14/2020)
`55 MOTION to Dismiss For Failure to State A Claim. Document filed by Novartis Pharma
`AG, Novartis Pharmaceuticals Corporation, Novartis Technology LLC..(Simmons, Ian)
`(Entered: 10/19/2020)
`56 MEMORANDUM OF LAW in Support re: 55 MOTION to Dismiss For Failure to State
`A Claim. . Document filed by Novartis Pharma AG, Novartis Pharmaceuticals
`Corporation, Novartis Technology LLC..(Simmons, Ian) (Entered: 10/19/2020)
`57 LETTER MOTION for Oral Argument on Motion to Dismiss For Failure to State a
`Claim addressed to Judge Alison J. Nathan from Ian Simmons dated October 15, 2020.
`Document filed by Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Novartis
`Technology LLC..(Simmons, Ian) (Entered: 10/19/2020)
`58 MOTION to Dismiss For Failure to State a Claim. Document filed by Vetter Pharma
`International GMBH..(Horton, Benjamin) (Entered: 10/19/2020)
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`10/17
`
`Regeneron Exhibit 1077.010
`
`

`

`4/13/2021
`10/22/2020
`
`10/22/2020
`
`10/23/2020
`
`10/23/2020
`
`10/28/2020
`
`10/30/2020
`
`11/02/2020
`
`11/02/2020
`
`SDNY CM/ECF NextGen Version 1.6
`59 CONSENT LETTER MOTION for Leave to File Excess Pages addressed to Judge
`Alison J. Nathan from Eric S. Hochstadt dated October 21, 2020. Document filed by
`Regeneron Pharmaceuticals Inc...(Hochstadt, Eric) (Entered: 10/22/2020)
`60 ORDER. On October 19, 2020, Defendant Regeneron Pharmaceuticals, Inc. filed a
`motion to dismiss. Dkt. No. 55. Pursuant to Rule 3.F of this Court's Individual Practices
`in Civil Cases, on or before October 29, 2020, Plaintiff must notify the Court and its
`adversary in writing whether (1) it intends to file an amended pleading and when it will
`do so or (2) it will rely on the pleading being attacked. Plaintiff is on notice that declining
`to amend its pleadings to timely respond to a fully briefed argument in the Defendants'
`October 19, 2020 motion to dismiss may well constitute a waiver of the Plaintiff's right to
`use the amendment process to cure any defects that have been made apparent by the
`Defendants' briefing, and as further set forth in this Order. If Plaintiff chooses to amend,
`Defendants may then (a) file an answer; (b) file a new motion to dismiss; or (c) submit a
`letter stating that they rely on the initially-filed motion to dismiss. Nothing in this Order
`alters the time to amend, answer or move provided by the Federal Rules of Civil
`Procedure or Local Rules. SO ORDERED. (Signed by Judge Alison J. Nathan on
`10/21/2020) (rjm) (Entered: 10/22/2020)
`61 ORDER: granting 59 Letter Motion for Leave to File Excess Pages. SO ORDERED.
`(Signed by Judge Alison J. Nathan on 10/23/2020) (ama) (Entered: 10/23/2020)
`62 STATUS REPORT. (Joint Status Letter) Document filed by Regeneron Pharmaceuticals
`Inc.. (Attachments: # 1 Text of Proposed Order Case Management Plan and (proposed)
`Scheduling Order).(Hochstadt, Eric) (Entered: 10/23/2020)
`63 MEMO ENDORSEMENT on re: 62 Status Report filed by Regeneron Pharmaceuticals
`Inc. ENDORSEMENT: The initial pretrial conference is hereby re-scheduled to October
`30, 2020 at 3:45 p.m. It will proceed by teleconference. At 3:45 p.m. on October 30, the
`parties shall call (888) 363-4749 and enter access code 9196964#. SO ORDERED.
`(Signed by Judge Alison J. Nathan on 10/28/2020) (ks) Telephone Conference set for
`10/30/2020 at 03:45 PM before Judge Alison J. Nathan. Modified on 11/6/2020 (ks).
`(Entered: 10/28/2020)
`64 ORDER: Due to a scheduling conflict, the initial pre-trial conference scheduled for today
`at 3:45 p.m. is hereby adjourned to Monday, November 2, 2020 at 3 p.m. At that time, the
`parties and members of the public may access the Court's dedicated conference line by
`calling (888) 363-4749 and entering access code 919-6964#. SO ORDERED. (Initial
`Conference set for 11/2/2020 at 03:00 PM before Judge Alison J. Nathan). (Signed by
`Judge Alison J. Nathan on 10/30/2020) (rjm) (Entered: 10/30/2020)
` Minute Entry for proceedings held before Judge Alison J. Nathan: Initial Pretrial
`Conference held on 11/2/2020. See Order. (Court Reporter Khris Sellin) (kwi) (Entered:
`11/02/2020)
`65 CIVIL CASE MANAGEMENT PLAN AND SCHEDULING ORDER: All parties do not
`consent to conducting all further proceedings before a United States Magistrate Judge,
`including motions and trial. Amended pleadings may not be filed and additional parties
`may not be joined except with leave of the Court. Any motion to amend or to join
`additional parties shall be filed within 30 days from the date of this Order. All fact
`discovery is to be completed no later than 10 months after IPC. Depositions shall be
`completed by close of fact discovery. All expert discovery, including disclosure of expert
`reports, production of underlying documents, and depositions shall be completed by 165
`days from fact discovery. Summary Judgment and Daubert motions are to be filed within
`30 days of the close of all discovery. The parties shall be ready for trial within two weeks
`of filing the Joint Pretrial Report. This case is to be tried to a jury. Case Management
`
`https://ecf.nysd.uscourts.gov/cgi-bin/DktRpt.pl?220714501785306-L_1_0-1
`
`11/17
`
`Regeneron Exhibit 1077.011
`
`

`

`4/13/2021
`
`11/02/2020
`
`11/02/2020
`
`11/02